Anti-erbB-2 (Her-2/neu) (4D5-8 (trastuzumab)), Human IgG1, CONJUmAb™, kappa

Anti-erbB-2 (Her-2/neu) (4D5-8 (trastuzumab)), Human IgG1, CONJUmAb™, kappa
Artikelnummer
ABAAb00103-10.0CM-CMV
Verpackungseinheit
5 mg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: 4D5-8 (trastuzumab)

Heavy Chain modification: CONJUmAb™

Antigen Long Description: A431 cells (human epidermoid carcinoma) (over)expressing EGFR.

Buffer Composition: PBS only

Uniprot Accession No.: P04626

Specificity Statement: Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.

Application Notes (Clone): This antibody binds to erbB-2/Her-2/neu has therapeutic indications particularly in the treatment of breast cancer (c.f. Herceptin). It can also be used to detect HER-2 by flow cytometry or IHC (Glazyrin 2007).
Mehr Informationen
Artikelnummer ABAAb00103-10.0CM-CMV
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab00103-10.0CM-CMV
Verpackungseinheit 5 mg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode ELISA, Flow Cytometry, Immunohistochemistry
Isotyp IgG1 kappa
Wirt Human
Produktinformation (PDF)
×
MSDS (PDF)
×